213 related articles for article (PubMed ID: 33692924)
81. Prognostic value of immunohistochemical classification of diffuse large B-cell lymphoma into germinal center B-cell and non-germinal center B-cell subtypes.
Saad AA; Awed NM; Abdel-Hafeez ZM; Kamal GM; Elsallaly HM; Alloub AI
Saudi Med J; 2010 Feb; 31(2):135-41. PubMed ID: 20174727
[TBL] [Abstract][Full Text] [Related]
82. Dysregulated expressions of PTEN, NF-κB, WWP2, p53 and c-Myc in different subtypes of B cell lymphoma and reactive follicular hyperplasia.
Fu H; Jin C; Zhu Q; Liu T; Ke B; Li A; Zhang T
Am J Transl Res; 2019; 11(2):1092-1101. PubMed ID: 30899409
[TBL] [Abstract][Full Text] [Related]
83. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features.
Liu Y; Yu K; Li M; Zeng K; Wei J; Li X; Liu Y; Zhao D; Fan L; Yu Z; Wang Y; Li Z; Zhang W; Bai Q; Yan Q; Guo Y; Wang Z; Guo S
Hum Pathol; 2017 Jun; 64():213-221. PubMed ID: 28438623
[TBL] [Abstract][Full Text] [Related]
84. Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.
Zhang YA; Yang X; Yao J; Ren Y; Liu P
Dis Markers; 2022; 2022():3276925. PubMed ID: 35774848
[TBL] [Abstract][Full Text] [Related]
85. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
[TBL] [Abstract][Full Text] [Related]
86. [Clinicopathological features of de novo CD5-positive diffuse large B-cell lymphoma].
Fan Y; Dong L; OUYang BS; Xu HM; Zheng SF; Wang AR; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):448-453. PubMed ID: 32392928
[No Abstract] [Full Text] [Related]
87. Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
Pedersen MØ; Gang AO; Brown P; Pedersen M; Knudsen H; Nielsen SL; Poulsen T; Wirenfeldt Klausen T; Høgdall E; Nørgaard P
PLoS One; 2017; 12(10):e0186983. PubMed ID: 29088292
[TBL] [Abstract][Full Text] [Related]
88. Clinicopathologic evaluation of subgroups of diffuse large B cell lymphoma by immunohistochemistry.
Naz E; Mirza T; Danish F
Asian Pac J Cancer Prev; 2011; 12(12):3335-9. PubMed ID: 22471476
[TBL] [Abstract][Full Text] [Related]
89. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma.
Su F; Lian K
Open Med (Wars); 2023; 18(1):20230819. PubMed ID: 37873542
[TBL] [Abstract][Full Text] [Related]
90. The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
Hwang J; Suh C; Kim K; Kim H; Kim AI; Craig JW; Chen KX; Roberson J; Guenette JP; Huang RY
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282799
[TBL] [Abstract][Full Text] [Related]
91. Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated
Liu Y; Ma X; Wu X; Hou X; Jin W; Fu L; Xun X; Yu Y; Shen Z
Leuk Lymphoma; 2024 May; ():1-11. PubMed ID: 38775302
[TBL] [Abstract][Full Text] [Related]
92. Prevalence And Clinical Significance Of Oncogenic
Chen YP; Ke LF; Lu JP; Wang JC; Zhu WF; Chen FF; Lin SF; Xu CW; Wu MJ; Chen G
Onco Targets Ther; 2019; 12():10165-10175. PubMed ID: 32063711
[TBL] [Abstract][Full Text] [Related]
93. Expression of c-Myc, Bcl2, Bcl6, and Cyclin D1 in High-Grade B-Cell Lymphoma.
Ali S; Rathore Z; Jahangir F; Rafique Z; Chughtai AS; Atiq A
Cureus; 2022 Sep; 14(9):e29527. PubMed ID: 36312606
[TBL] [Abstract][Full Text] [Related]
94. Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma.
Küçükzeybek BB; Bener S; Çallı AO; Paksoy TD; Payzin B
Turk J Haematol; 2013 Sep; 30(3):275-82. PubMed ID: 24385807
[TBL] [Abstract][Full Text] [Related]
95. Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma.
Liu MK; Cheng LL; Yi HM; He Y; Li X; Fu D; Dai YT; Fang H; Cheng S; Xu PP; Qian Y; Feng Y; Liu Q; Wang L; Zhao WL
Front Oncol; 2022; 12():885011. PubMed ID: 36276140
[TBL] [Abstract][Full Text] [Related]
96. Correlation between Immunohistochemical Subtype and Clinicopathological Features in Patients with Diffuse Large B-cell Lymphoma.
Patrascu AM; Streba L; Patrascu Ş; Nacea J; Mogoanta L; Rotaru I
Curr Health Sci J; 2017; 43(3):253-257. PubMed ID: 30595885
[TBL] [Abstract][Full Text] [Related]
97. Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.
Papageorgiou SG; Thomopoulos TP; Katagas I; Bouchla A; Pappa V
Ther Adv Hematol; 2021; 12():20406207211013987. PubMed ID: 34104369
[TBL] [Abstract][Full Text] [Related]
98. Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma.
Takada R; Watanabe T; Sekai I; Yoshikawa K; Hara A; Otsuka Y; Yoshikawa T; Kamata K; Minaga K; Komeda Y; Chikugo T; Arai Y; Yamashita K; Kudo M
Front Oncol; 2021; 11():656219. PubMed ID: 34123811
[TBL] [Abstract][Full Text] [Related]
99. The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor Prognosis in DLBCL.
Lone M; Shadang M; Akhter Q; Kumar M; Mallick S; Gogia A; Nilima N; Chauhan SS; Mir RA
Pathobiology; 2022; 89(3):146-156. PubMed ID: 35078195
[TBL] [Abstract][Full Text] [Related]
100. Mutant Phenotype p53 Immunohistochemical Expression Is Associated With Poor Prognostic Parameters and Disease-Free Survival in Triple-Negative Metaplastic Breast Carcinoma.
Hashmi AA; Sajid A; Hussain M; Zia S; Islam S; Diwan MA; Ali SM; Irfan M; Shamail F; Zia F
Cureus; 2021 May; 13(5):e15244. PubMed ID: 34188985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
